BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Francelle L, Outeiro TF, Rappold GA. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity. Sci Rep 2020;10:6064. [PMID: 32269243 DOI: 10.1038/s41598-020-62678-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Smida K, Albedah M, Rashid RF, Al-qawasmi A. Molecular dynamics method for targeting α-synuclein aggregation induced Parkinson's disease using boron nitride nanostructures. Engineering Analysis with Boundary Elements 2023;146:89-95. [DOI: 10.1016/j.enganabound.2022.10.016] [Reference Citation Analysis]
2 Pulya S, Ghosh B. Epigenetics of Memory Processes. Handbook of Epigenetics 2023. [DOI: 10.1016/b978-0-323-91909-8.00018-9] [Reference Citation Analysis]
3 Sreenivasmurthy SG, Iyaswamy A, Krishnamoorthi S, Reddi RN, Kammala AK, Vasudevan K, Senapati S, Zhu Z, Su C, Liu J, Guan X, Chua K, Cheung K, Chen H, Zhang H, Zhang Y, Song J, Kumar Durairajan SS, Li M. Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.1030534] [Reference Citation Analysis]
4 Hu JX, Ma WJ, He LY, Zhang CH, Zhang C, Wang Y, Chen CN, Shen DY, Gao HM, Guo RR, Ning QQ, Ye XC, Cui GY, Li L. Macrophage migration inhibitory factor (MIF) acetylation protects neurons from ischemic injury. Cell Death Dis 2022;13:466. [PMID: 35585040 DOI: 10.1038/s41419-022-04918-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Mazzocchi M, Goulding SR, Morales-Prieto N, Foley T, Collins LM, Sullivan AM, O'Keeffe GW. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease. Brain Behav Immun 2022;102:151-60. [PMID: 35217173 DOI: 10.1016/j.bbi.2022.02.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fleming A, Bourdenx M, Fujimaki M, Karabiyik C, Krause GJ, Lopez A, Martín-Segura A, Puri C, Scrivo A, Skidmore J, Son SM, Stamatakou E, Wrobel L, Zhu Y, Cuervo AM, Rubinsztein DC. The different autophagy degradation pathways and neurodegeneration. Neuron 2022:S0896-6273(22)00056-3. [PMID: 35134347 DOI: 10.1016/j.neuron.2022.01.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
7 Blasl AT, Schulze S, Qin C, Graf LG, Vogt R, Lammers M. Post-translational lysine ac(et)ylation in health, ageing and disease. Biol Chem 2021. [PMID: 34433238 DOI: 10.1515/hsz-2021-0139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Onishi T, Maeda R, Terada M, Sato S, Fujii T, Ito M, Hashikami K, Kawamoto T, Tanaka M. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice. Sci Rep 2021;11:15423. [PMID: 34326423 DOI: 10.1038/s41598-021-94923-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Du Y, Yang X, Li Z, Le W, Hao Y, Song Y, Wang F, Guan Y. HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy. Neurochem Int 2021;149:105141. [PMID: 34298079 DOI: 10.1016/j.neuint.2021.105141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
10 Cacabelos R, Carrera I, Martínez O, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Nebril L, Tellado I, Cacabelos N, Pego R, Naidoo V, Carril JC. Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Med Res Rev 2021;41:2841-86. [PMID: 34106485 DOI: 10.1002/med.21838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li B, Yang Y, Wang Y, Zhang J, Ding J, Liu X, Jin Y, Lian B, Ling Y, Sun C. Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models. iScience 2021;24:102302. [PMID: 33851105 DOI: 10.1016/j.isci.2021.102302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Cappelletti G, Calogero AM, Rolando C. Microtubule acetylation: A reading key to neural physiology and degeneration. Neurosci Lett 2021;755:135900. [PMID: 33878428 DOI: 10.1016/j.neulet.2021.135900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
13 Vital TPR, Nayak J, Naik B, Jayaram D. Probabilistic Neural Network-based Model for Identification of Parkinson’s Disease by using Voice Profile and Personal Data. Arab J Sci Eng 2021;46:3383-3407. [DOI: 10.1007/s13369-020-05080-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Follett J, Farrer MJ. LRRK2; a dynamic regulator of cellular trafficking. Brain Res 2021;1761:147394. [PMID: 33662339 DOI: 10.1016/j.brainres.2021.147394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Tago T, Toyohara J, Ishii K. Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain. ACS Chem Neurosci 2021;12:746-55. [PMID: 33502174 DOI: 10.1021/acschemneuro.0c00774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Auzmendi-Iriarte J, Matheu A. Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma. Front Aging Neurosci 2020;12:630743. [PMID: 33633561 DOI: 10.3389/fnagi.2020.630743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Chakravarty S, Bhat UA, Reddy RG, Gupta P, Kumar A. Histone Deacetylase Inhibitors and Psychiatric Disorders. Epigenetics in Psychiatry 2021. [DOI: 10.1016/b978-0-12-823577-5.00016-7] [Reference Citation Analysis]
18 Boiarska Z, Passarella D. Microtubule-targeting agents and neurodegeneration. Drug Discov Today 2021;26:604-15. [PMID: 33279455 DOI: 10.1016/j.drudis.2020.11.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Pulya S, Amin SA, Adhikari N, Biswas S, Jha T, Ghosh B. HDAC6 as privileged target in drug discovery: A perspective. Pharmacol Res 2021;163:105274. [PMID: 33171304 DOI: 10.1016/j.phrs.2020.105274] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 18.0] [Reference Citation Analysis]
20 Wang R, Sun H, Wang G, Ren H. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease. Int J Mol Sci 2020;21:E7182. [PMID: 33003340 DOI: 10.3390/ijms21197182] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Lemos M, Stefanova N. Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies. Front Synaptic Neurosci 2020;12:586453. [PMID: 33041780 DOI: 10.3389/fnsyn.2020.586453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]